Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort

被引:73
作者
Latimer, Caitlin S. [1 ]
Burke, Bridget T. [2 ]
Liachko, Nicole F. [3 ,4 ]
Currey, Heather N. [3 ]
Kilgore, Mitchell D. [1 ]
Gibbons, Laura E. [5 ]
Henriksen, Jonathan [1 ]
Darvas, Martin [1 ]
Domoto-Reilly, Kimiko [6 ]
Jayadev, Suman [6 ]
Grabowski, Tom J. [6 ,7 ]
Crane, Paul K. [5 ]
Larson, Eric B. [2 ]
Kraemer, Brian C. [3 ,4 ,8 ]
Bird, Thomas D. [3 ,6 ,9 ]
Keene, C. Dirk [1 ]
机构
[1] Univ Washington, Dept Pathol, Div Neuropathol, Seattle, WA 98104 USA
[2] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA
[3] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA
[4] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA USA
[5] Univ Washington, Dept Med, Seattle, WA USA
[6] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[7] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
[8] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[9] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
Resistance; Resilience; Alzheimer's disease neuropathologic change; TDP-43; Hyperphosphorylated tau; Dementia; C; elegans; COGNITIVE IMPAIRMENT; HIPPOCAMPAL SCLEROSIS; APOLIPOPROTEIN-E; NEUROPATHOLOGIC ASSESSMENT; BRAIN PATHOLOGIES; ADULT CHANGES; LATE-LIFE; NATIONAL INSTITUTE; LINGUISTIC ABILITY; AUTOPSY COHORT;
D O I
10.1186/s40478-019-0743-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease neuropathologic change (ADNC) is defined by progressive accumulation of beta-amyloid plaques and hyperphosphorylated tau (pTau) neurofibrillary tangles across diverse regions of brain. Non-demented individuals who reach advanced age without significant ADNC are considered to be resistant to AD, while those burdened with ADNC are considered to be resilient. Understanding mechanisms underlying ADNC resistance and resilience may provide important clues to treating and/or preventing AD associated dementia. ADNC criteria for resistance and resilience are not well-defined, so we developed stringent pathologic cutoffs for non-demented subjects to eliminate cases of borderline pathology. We identified 14 resistant (85+ years old, non-demented, Braak stage <= III, CERAD absent) and 7 resilient (non-demented, Braak stage VI, CERAD frequent) individuals out of 684 autopsies from the Adult Changes in Thought study, a long-standing community-based cohort. We matched each resistant or resilient subject to a subject with dementia and severe ADNC (Braak stage VI, CERAD frequent) by age, sex, year of death, and post-mortem interval. We expanded the neuropathologic evaluation to include quantitative approaches to assess neuropathology and found that resilient participants had lower neocortical pTau burden despite fulfilling criteria for Braak stage VI. Moreover, limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) was robustly associated with clinical dementia and was more prevalent in cases with high pTau burden, supporting the notion that resilience to ADNC may depend, in part, on resistance to pTDP-43 pathology. To probe for interactions between tau and TDP-43, we developed a C. elegans model of combined human (h) Tau and TDP-43 proteotoxicity, which exhibited a severe degenerative phenotype most compatible with a synergistic, rather than simply additive, interaction between hTau and hTDP-43 neurodegeneration. Pathways that underlie this synergy may present novel therapeutic targets for the prevention and treatment of AD.
引用
收藏
页数:24
相关论文
共 101 条
[1]   "End-Stage" Neurofibrillary Tangle Pathology in Preclinical Alzheimer's Disease: Fact or Fiction? [J].
Abner, Erin L. ;
Kryscio, Richard J. ;
Schmitt, Frederick A. ;
SantaCruz, Karen S. ;
Jicha, Gregory A. ;
Lin, Yushun ;
Neltner, Janna M. ;
Smith, Charles D. ;
Van Eldik, Linda J. ;
Nelson, Peter T. .
JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (03) :445-453
[2]   TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease [J].
Amador-Ortiz, Catalina ;
Lin, Wen-Lang ;
Ahmed, Zeshan ;
Personett, David ;
Davies, Peter ;
Dara, Ranjan ;
Graff-Radford, Neill R. ;
Hutton, Michael L. ;
Dickson, Dennis W. .
ANNALS OF NEUROLOGY, 2007, 61 (05) :435-445
[3]   Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A [J].
Aoki, Naoya ;
Murray, Melissa E. ;
Ogaki, Kotaro ;
Fujioka, Shinsuke ;
Rutherford, Nicola J. ;
Rademakers, Rosa ;
Ross, Owen A. ;
Dickson, Dennis W. .
ACTA NEUROPATHOLOGICA, 2015, 129 (01) :53-64
[4]  
APA, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]
[5]   Resistance vs resilience to Alzheimer disease Clarifying terminology for preclinical studies [J].
Arenaza-Urquijo, Eider M. ;
Vemuri, Prashanthi .
NEUROLOGY, 2018, 90 (15) :695-703
[6]   Cerebral Amyloid Angiopathy Pathology and Cognitive Domains in Older Persons [J].
Arvanitakis, Zoe ;
Leurgans, Sue E. ;
Wang, Zhenxin ;
Wilson, Robert S. ;
Bennett, David A. ;
Schneider, Julie A. .
ANNALS OF NEUROLOGY, 2011, 69 (02) :320-327
[7]   Neuropathology of older persons without cognitive impairment from two community-based studies [J].
Bennett, D. A. ;
Schneider, J. A. ;
Arvanitakis, Z. ;
Kelly, J. F. ;
Aggarwal, N. T. ;
Shah, R. C. ;
Wilson, R. S. .
NEUROLOGY, 2006, 66 (12) :1837-1844
[8]   Education modifies the relation of AD pathology to level of cognitive function in older persons [J].
Bennett, DA ;
Wilson, RS ;
Schneider, JA ;
Evans, DA ;
de Leon, CFM ;
Arnold, SE ;
Barnes, LL ;
Bienias, JL .
NEUROLOGY, 2003, 60 (12) :1909-1915
[9]   Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR [J].
Borgatti, Antonella ;
Koopmeiners, Joseph S. ;
Sarver, Aaron L. ;
Winter, Amber L. ;
Stuebner, Kathleen ;
Todhunter, Deborah ;
Rizzardi, Anthony E. ;
Henriksen, Jonathan C. ;
Schmechel, Stephen ;
Forster, Colleen L. ;
Kim, Jong-Hyuk ;
Froelich, Jerry ;
Walz, Jillian ;
Henson, Michael S. ;
Breen, Matthew ;
Lindblad-Toh, Kerstin ;
Oh, Felix ;
Pilbeam, Kristy ;
Modiano, Jaime F. ;
Vallera, Daniel A. .
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) :956-965
[10]  
Braak H, 1991, ACTA NEUROPATHOL